Cancer Imaging and Multi-Omics Research (CIMORe) - MR - ISB

CIMORe - Cancer Imaging and Multi-Omics Research Group

Group photo of the CIMORe group.

Research activity

The Cancer Imaging and Multi-Omics Research Group (CIMORe - former MR Cancer Group) at NTNU, headed by Professor Tone F. Bathen, focuses on the use of imaging and molecular analyses to describe functional and metabolic characteristics of cancer. The group has more than 25 years of experience from clinical MRI and NMR based metabolomics studies in cancer.

We have recently expanded our imaging-based methodological repertoire to include PET for in vivo molecular imaging and MALDI to obtain spatially resolved data from heterogeneous cancer tissue ex vivo. We aim to improve our understanding of underlying biological processes by applying multilevel molecular analysis methods to biological data. In addition, we use advanced image analysis and artificial intelligence for improved decision support in cancer detection and characterization.

Our long-term objective is to improve and individualize cancer treatment by developing integrated methods and data analysis tools for functional and molecular assessment of tumors. We use a broad spectrum of systems for cancer studies, spanning from cultured cancer cells and relevant animal models to humans. We have access to dedicated MR equipment for in vitro, ex vivo, preclinical and clinical research.

The group’s translational approach to cancer research benefits from the close integration between NTNU and St. Olavs University Hospital. The group is highly interdisciplinary with research scientists, Post Docs and PhDs with backgrounds from medical physics, molecular biology, medicine, bioinformatics, pharmacy, chemistry, and data science.